Entero Therapeutics, Stock Alpha and Beta Analysis
| ENTO Stock | 0.47 0.01 2.17% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Entero Therapeutics,. It also helps investors analyze the systematic and unsystematic risks associated with investing in Entero Therapeutics, over a specified time horizon. Remember, high Entero Therapeutics,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Entero Therapeutics,'s market risk premium analysis include:
Beta 3.45 | Alpha 0.28 | Risk 12.52 | Sharpe Ratio 0.0632 | Expected Return 0.79 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Entero |
Entero Therapeutics, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Entero Therapeutics, market risk premium is the additional return an investor will receive from holding Entero Therapeutics, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Entero Therapeutics,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Entero Therapeutics,'s performance over market.| α | 0.28 | β | 3.45 |
Entero Therapeutics, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Entero Therapeutics,'s Buy-and-hold return. Our buy-and-hold chart shows how Entero Therapeutics, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Entero Therapeutics, Market Price Analysis
Market price analysis indicators help investors to evaluate how Entero Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entero Therapeutics, shares will generate the highest return on investment. By understating and applying Entero Therapeutics, stock market price indicators, traders can identify Entero Therapeutics, position entry and exit signals to maximize returns.
Entero Therapeutics, Return and Market Media
The median price of Entero Therapeutics, for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 0.44 with a coefficient of variation of 26.71. The daily time series for the period is distributed with a sample standard deviation of 0.13, arithmetic mean of 0.48, and mean deviation of 0.11. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 | 09/20/2024 |
2 | Disposition of 476 shares by Romano Sarah of Entero Therapeutics, at 0.446 subject to Rule 16b-3 | 10/09/2024 |
3 | Matinas BioPharma Holdings, Inc. Sees Large Increase in Short Interest | 10/30/2024 |
4 | Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 | 11/13/2024 |
5 | ABVC BioPharma GAAP EPS of -0.02, revenue of 0.38M | 11/14/2024 |
6 | Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate | 11/19/2024 |
7 | Spine BioPharma, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference | 11/21/2024 |
8 | Hillstream BioPharma Terminates Agreement with Intract Pharma Ltd, Appoints New Board MemberWASHINGTON, D.C. On November 20, 2024, Tharimmune, Inc., with its pr... | 11/22/2024 |
9 | Quantum BioPharma Previously Known as FSD Pharma Invites Shareholders to Come Forward and Join Hands With the Company in the US700M Court Case the Company Has F... | 11/25/2024 |
10 | Matinas BioPharma announces board member resignation | 11/27/2024 |
About Entero Therapeutics, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Entero or other stocks. Alpha measures the amount that position in Entero Therapeutics, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Entero Therapeutics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Entero Therapeutics,'s short interest history, or implied volatility extrapolated from Entero Therapeutics, options trading.
Build Portfolio with Entero Therapeutics,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Entero Therapeutics, Backtesting, Entero Therapeutics, Valuation, Entero Therapeutics, Correlation, Entero Therapeutics, Hype Analysis, Entero Therapeutics, Volatility, Entero Therapeutics, History and analyze Entero Therapeutics, Performance. To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Entero Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.